Life Experiences of Patients Using Oral Anticoagulant

Abstract

Objective: The aim of the study is to examine the life experiences of individuals receiving oral anticoagulant therapy. Material and Methods: The research was carried out with face-to-face semi-structured interviews (n = 16) using the qualitative research method from the qualitative research design. All interviews were recorded by the mobile phone audio record programme and the interviews were transcribed into the text and evaluated in the Nvivo 8.0 packet program. Results: The average age of the participants in the study was 58 ± 10.56 years. In the research, themes related to drug use knowledge and awareness, drug benefit perception, drug harm perception, treatment satisfaction, and its effect on daily life were determined. Conclusion: Awareness/knowledge, benefit and harm perception, impact on daily life and treatment satisfaction were defined within the scope of five main themes. It is recommended that healthcare professionals consider these themes determined in the training programs they will plan for patients.

Keywords

• Oral Anticoagulant
• heart disease
• qualitative research.
• life experience

Oral Antikoagülan Kullanan Hastaların Yaşam Deneyimleri

Abstract

Amaç: Araştırmanın amacı oral antikoagülan tedavi alan bireylerin yaşam deneyimlerinin incelenmesidir. Gereç ve Yöntem: Araştırma verileri nitel araştırma deseninden olgu bilim yöntemi kullanılarak yüz yüze yarı yapılandırılmış görüşme tekniği kullanılarak (n=16) toplandı. Tüm görüşmeler cep telefonu ses kayıt programı kullanılarak kayıt altına alındı. Veriler metne dönüştürülerek, Nvivo 8.0 paket programında değerlendirildi. Bulgular: Araştırmaya katılanların yaş ortalaması 58±10,56 idi. Araştırmada ilaç kullanım bilgisi ve farkındalık, ilaç yarar algısı, ilaç zarar algısı, tedavi memnuniyeti, günlük yaşama etkisi ile ilgili temalar belirlendi. Sonuç: Belirlenen beş ana tema; bilgi/farkındalık, yarar ve zarar algısı, günlük yaşama etki ve tedavi memnuniyetidir. Sağlık çalışanlarının hastalar için planlayacakları eğitim programlarında belirlenen bu temaları göz önünde bulundurmaları önerilmektedir.

Keywords

• Oral Antikoagülan
• kalp hastalığı
• nitel araştırma
• yaşam deneyimi

References

1. Osasu YM, Mitchell C, Cooper R. Use of direct oral anticoagulants in primary care: a qualitative study integrating patient and practitioner perspectives. BJGP Open. 2022;6(4):BJGPO.2021.0226.
2. Yıldırım JG. Yaşamınızı nasıl dengede tutabilirsiniz? Pıhtı-önler ilaç (Coumadin /Varfarin) kullanan hastalar için bakım rehberi. Bayık Temel A, editör. 1. Baskı. İstanbul: Kazmaz Matbaacılık; 2013.p.1-152.
3. ESC Klavuzu. Atriyal fibrilasyon tedavisi ESC kılavuzunun 2012 odaklı güncellemesi. Türk Kardiyol Dern. 2013;Suppl.3:53-85.
4. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, et al. Atriyal fibrilasyon tedavi kılavuzu. Türk Kardiyol Dern. 2010;38(4):1-65.
5. Oto A. Türk Kardiyoloji derneği atriyal fibrilasyon tanı ve tedavi kılavuzu. Türk Kardiyol Dern. 2003;31(12):737-762.
6. Clarkesmith DE, Lip GY, Lane DA. Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study. Thrombosis Res 2017;153(1):19-27.
7. Kılıç S, Çelik A, Çekirdekçi E, Altay S, Elçik D, Akboğa MK, et al. The Prevalence and Risks of Inappropriate Combination of Aspirin and Warfarin in Clinical Practice: Results From WARFARIN-TR Study. Balkan Med J. 2019 Jan 1;36(1):17-22. doi: 10.4274/balkanmedj.2017.1472. Epub 2018 Aug 6. PMID: 30079702; PMCID: PMC6335934.
8. Uçar A, Arslan S. Perception of treatment satisfaction in patients who receive warfarin therap in Turkey. Int J Caring Sci. 2021;14(1):570-580.

9. Hirsh J, Dalen J, Guyatt G. The sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. Chest. 2001;119(1):1-2.
10. Park S, Jang I. Factors affecting medication adherence in patients with mechanical heart valves taking warfarin: the role of knowledge on warfarin, medication belief, depression, and self-efficacy. Int J Environ Res Public Health. 2021;18(10):5214.
11. Xuereb CB, Shaw RL, Lane DA. Patients’ and health professionals’ views and experiences of atrial fibrillation and oral-anticoagulant therapy: a qualitative meta-synthesis. Patient Educ Couns. 2012;88(2):330-337.
12. Viola R, Fekete H, Csoka I. Patients' knowledge on oral anticoagulant treatment in Hungary. Int J Clin Pharm. 2017;39(6):1265-1272.
13. Lee NC, Wasson DR, Anderson MA, Stone S, Gittings JA. A survey of patient education post discharge. J Nurs Care Qual. 1998;13:63-70.
14. Yıldırım JG, Bayık-Temel A. The validity and reliability of Turkish version of the Duke anticoagulation satisfaction scale. Turk Gogus Kalp Dama. 2014;22(4):761-772.
15. Cheah G, Martens K. Coumadin knowledge deficits: Do recently hospitalized patients know how to safely manage the medication? Home Healthc Nurse. 2003;21(2):94-100.
16. Briggs AL, Jackson TR, Bruce S, Shapiro NL. The development and performance validation of a tool to asses’ patient anticoagulation knowledge. Res Social Adm Pharm. 2005;1(1):40-59.
17. Yıldırım JG, Bayık-Temel A. The effect of nurse home-support program on self-management of patients receiving oral anticoagulation (Warfarin) therapy. FNJN. 2020;28(1):13-22.
18. Donaldson G, Goh KY, Tiwari P, Maini S, Ram B, Dwivedi RC. Anti-thrombotics and their impact on inpatient epistaxis management: a tertiary centre experience. Ir J Med Sci. 2022;191(4):1621-1629.
19. Bajorek BV, Krass I, Ogle SJ, Duguid MJ, Shenfield GM. Warfarin use in the elderly: The nurses’ perspective. Aust J Adv Nurs. 2006;23(3):19-25.
20. Fang MC, Machtinger EC, Wang F, Schillinger D. Health literacy and anticoagulation-related outcomes among patients taking warfarin. J Gen Intern Med. 2006;21(8):841–846.
21. Lipman T, Murtagh MJ, Thomson R. How research-conscious GPs make decisions about anticoagulation in patients with atrial fibrillation: a qualitative study. Fam Pract. 2004;21(3):290-298.
22. Shah SGS, Robinson I. Patients’ perspectives on self-testing of oral anticoagulation therapy: Content analysis of patients’ internet blogs. BMC Health Serv Res. 2011;11(25):1-13.
23. Wilson FL, Templin TN, Nordstrom CK, Carter JM, Baker L, Kinney T, et. al. Psychometric Properties and Construct Validity of the Knowledge Information Profile-Coumadin. J Pharm Technol. 2015 Feb;31(1):20-28. doi: 10.1177/8755122514548594. Epub 2014 Sep 4. PMID: 34860925; PMCID: PMC5990169.
24. Monz BU, Connolly SJ, Korhonen M, Noack H, Pooley J. Assessing the impact of dabigatran and warfarin on health-related quality of life: results from an RE-LY sub-study. Int J Cardiol. 2013;168(3):2540-2547.
25. Yıldırım A, Şimşek H. Sosyal bilimlerde nitel araştırma yöntemleri, 11. Baskı, Ankara: Seçkin Yayıncılık. 2018. p. 67-74.
26. Erdoğan S, Nahcivan N, Esin N. Hemşirelikte Araştırma In: Erdoğan S. Nitel araştırmalar. 2. Baskı. İstanbul: Nobel Tıp. 2015.p.133-164.